Anapharm Europe validates new LC/MS/MS bioanalytical method for Tiotropium

Anapharm Europe has successfully developed and validated a bioanalytical method for determination of Tiotropium in human plasma by LC/MS/MS. This method with a Limit of Quantification as low as 0.5 pg/mL adds to the list of high sensitivity methods for inhalers, including Fluticasone and Salmeterol.


30/10/2020 12:49

Successful WHO Inspection

Anapharm Bioanalytics is proud to announce that it has successfully undergone World Health Organization GCP/GLP compliance inspection at its Barcelona based bioanalytical lab

08/05/2020 14:29

Cell Lab | Anapharm Bioanalytics expands its laboratory capabilities

We are glad to inform you that a cell lab has recently been built at our facilities in Barcelona. Our brand new cell lab capabilities will enable the development and validation of a variety of assays such as Cell Proliferation, Ligand Stimulated Cell Signalling, Protein Secretion, Reporter Gene, NAbs, etc.

31/03/2020 10:03

Anapharm Bioanalytics Brazilian ANVISA Certificate Renewal

Anapharm Bioanalytics is proud to announce that it has recently (February 20th, 2020) renewed its ANVISA (Brazil) certificate. The renewed certification is valid until February 20th, 2022.